Company intelligence / Profile preview

George Huntington Institute

Münster, Nordrhein-Westfalen, Germany

Ownership: Private
Development stage: Other

Overview

George Huntington Institute is one of the world’s largest Huntington's disease (HD) outpatient clinics, serving as a clinical site for international HD studies and trials, with deep involvement in preclinical and clinical research aimed at improving care and exploring future therapies for HD. It provides infrastructure and resources for research, patient care, and supports clinical trial participation including studies such as ENROLL-HD and HD-Clarity.

Therapeutic areas: Neurology
Industry: Academic Hospital/University/Research

Partnerships

IDEA-FAST consortiumENROLL-HDCHDI Foundation (transgenic pig project)HD-Clarity

Beyond the preview

Go deeper on George Huntington Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on George Huntington Institute.

Explore the full profile